Marumi Ohno1, Masahiko Negishi1. 1. National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Abstract
The N-terminal domain (NTD) of nuclear receptor superfamily members has been recently reported to regulate functions of the receptor through the interaction between the NTD and the C-terminal ligand binding domain (LBD), so-called an N/C interaction. Although this N/C interaction has been demonstrated in various nuclear receptors, eg, androgen receptor, this concept has not been observed in glucocorticoid receptor (GR). We hypothesized that GR requires its co-chaperone CCRP (cytoplasmic constitutive active/androstane receptor retention protein) to form a stable N/C interaction. This hypothesis was examined by co-immunoprecipitation assays using GR fragments overexpressing COS-1 cell lysate. Here, we demonstrated that GR undergoes the N/C interaction between the 26VMDFY30 motif in the NTD and the LBD. More importantly, co-chaperone CCRP is now found to induce this interaction. By the fact that a negative charge at Y30 disrupts this interaction, this residue, a potential phosphorylation site, was indicated to regulate the GR N/C interaction critically. Utilizing Y30F and Y30E mutants as N/C interacting and noninteracting forms of GR, respectively, a 2-dimensional blue native/sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed to examine whether or not the N/C interaction regulated formation of GR complexes. A cDNA microarray analysis was performed with COS-1 cells expressing Y30F or Y30E. We will present experimental data to demonstrate that CCRP is essential for GR to form the N/C interaction and will discuss its implications in GR functions.
The N-terminal domain (NTD) of nuclear receptor superfamily members has been recently reported to regulate functions of the receptor through the interaction between the NTD and the C-terminal ligand binding domain (LBD), so-called an N/C interaction. Although this N/C interaction has been demonstrated in various nuclear receptors, eg, androgen receptor, this concept has not been observed in glucocorticoid receptor (GR). We hypothesized that GR requires its co-chaperoneCCRP (cytoplasmic constitutive active/androstane receptor retention protein) to form a stable N/C interaction. This hypothesis was examined by co-immunoprecipitation assays using GR fragments overexpressing COS-1 cell lysate. Here, we demonstrated that GR undergoes the N/C interaction between the 26VMDFY30 motif in the NTD and the LBD. More importantly, co-chaperoneCCRP is now found to induce this interaction. By the fact that a negative charge at Y30 disrupts this interaction, this residue, a potential phosphorylation site, was indicated to regulate the GR N/C interaction critically. Utilizing Y30F and Y30E mutants as N/C interacting and noninteracting forms of GR, respectively, a 2-dimensional blue native/sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed to examine whether or not the N/C interaction regulated formation of GR complexes. A cDNA microarray analysis was performed with COS-1 cells expressing Y30F or Y30E. We will present experimental data to demonstrate that CCRP is essential for GR to form the N/C interaction and will discuss its implications in GR functions.
Nuclear receptors are, in general, defined as ligand-activated transcription factors.
They are featured by their domain structures with N-terminus domain (NTD), DNA
binding domain (DBD), and C-terminal ligand binding domain (LBD). Transcriptional
activation functions are present in the NTD and the LBD of nuclear receptors. The
LBD regulates ligand-dependent transcriptional activities whereas the functions of
NTD are thought to be constitutively activated and to be somehow suppressed by the
LBD. Recent studies have been increasingly emphasized an interdomain interaction
between the NTD and the LBD, so-called an N/C interaction, as a regulatory
determinant of nuclear receptor functions. Androgen receptor (AR) is the best-known
nuclear receptor that undergoes an N/C interaction to fully elicit its
transcriptional activity. The interaction is mediated by the binding of the LBD to a
specific FXXLF sequence in the NTD and serves to modulate protein-protein
interactions of AR.[1-4] The N/C interaction regulates AR
functions including protein stability, dimerization, and gene activation.[5-8] The N/C interaction-defective
mouse model (deletion of FXXLF) showed a clear delay of neurodegeneration induced by
aggregation of AR with an expanded glutamine repeat, further confirming a
physiological importance of this interdomain interactions for nuclear receptor regulation.[5] Whereas the N/C interactions were also demonstrated in various other nuclear
receptors, progesterone receptor (PR), estrogen receptor alpha (ERα), and
mineralocorticoid receptor (MR), this concept has not yet been observed in
glucocorticoid receptor (GR).[9-11] Whereas the
N/C interactions of AR, PR, and MR are induced by ligand binding, the ERα N/C
interaction does not require ligands and is suggested to be modified by
cell-specific factors such as co-chaperone proteins.[3,9-11] It brought us a hypothesis
that GR utilizes a co-chaperone protein to form a stable N/C interaction. Here, we
have investigated whether GR requires co-chaperoneCCRP (cytoplasmic constitutive
active/androstane receptor retention protein) for the N/C interaction and what the
biological significance is.CCRP is a member of heat shock protein (HSP) 40/DNAJ family with a characteristic
J-domain. Having 2 tetratricopeptide (TPR) motifs, CCRP is also characterized as a
protein that belongs to the TPR family. Both J- and TPR-domains mediate
protein-protein interactions, suggesting that CCRP modulates intermolecular and
intramolecular interactions. Our group previously demonstrated an interaction of
CCRP with nuclear receptor constitutive active/androstane receptor (CAR) to
stabilize a CAR-HSP90 complex and retain the receptor in the cytoplasm of HepG2
cells, with which the name cytoplasmic CAR retention protein (CCRP) was coined to
this protein.[12] Subsequently, CCRP knockout (KO) mice were utilized to determine the role of
CCRP in CAR-mediated activation of Cyp2b10 gene in the liver.[13] In addition to CAR, CCRP has been shown to interact with other nuclear
receptors including pregnane X receptor, PR, AR, MR, ERα, and GR.[14-17] However, a role of CCRP in the
regulation of nuclear receptor functions is largely unclear.In the present study, co-immunoprecipitation (co-IP) assays were employed to
determine an N/C interaction of GR between a short peptide
(26VMDFY30) near the N-terminus of NTD and the LBD in
COS-1 cells. Then, these co-immunoprecipitations were performed with or without
co-expression of CCRP to confirm the regulatory roles of CCRP in this N/C
interaction. In addition, utilizing the fact that phosphor-mimic mutation of
tyrosine within the VMDFY motif to glutamic acid abolished this N/C interaction,
either GR Y30F or GR Y30E mutant was ectopically expressed in COS-1 cells for a
subsequent 2-dimensional blue native/sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (2D-BN/SDS-PAGE). Here, we have presented experimental evidence that
GR undergoes the CCRP-mediated N/C interaction, and a possibility that GR regulates
different functions through the N/C interaction is discussed.
Materials and Methods
Plasmid Construction
The plasmids used in this study included FLAG-6c-CMV-hGRα (referred as FLAG-GR;
full length, 1-777; ΔLBD, 1-527; ΔNTD, 1-25/394-777; LBD, 528-777; Δ26-76,
1-25/77-777; Y30F and Y30E), enhanced yellow fluorescent protein
(EYFP)-c1-hGRα-26-76 (referred as EYFP-26/76; WT, AADFY, VMDAA, Y30F, and Y30E),
and pcDNA3.1-mCCRP-V5 (referred as CCRP-V5). EYFP-c1-hGRα was a kind gift from
Dr Cidlowski (National Institute of Environmental Health Sciences, Research
Triangle Park, North Carolina). GRα coding region was subcloned into a
FLAG-6c-CMV vector. Mutations were introduced using a Prime STAR MAX DNA
polymerase (Takara, Otsu, Japan) according to the manufacturer’s instruction.
The CCRP-V5 expression vector was obtained as previously described.[12] Sequences of all plasmids were confirmed by DNA sequencing.
Cell Culture and Transfection
The African green monkey kidney cell line, COS-1 cells were cultured in
Dulbecco’s Modified Eagle Medium (11965-092, Invitrogen, Carlsbad, California)
supplemented with 10% fetal bovine serum in a humidified 5% CO2
incubator at 37°C. Endogenous expression of CCRP in COS-1 cells was examined by
Western blot analysis and found to be not detected (Supplemental Figure 1). COS-1 cells were transiently transfected
with expression plasmids by reverse transfection technique using FuGENE 6
(Promega, Madison, Wisconsin) according to the manufacturer’s protocol. After 40
hours post-transfection, cells were used for each experiment as described
individually below.
Co-IP Assay
Schematic representation of FLAG- or EYFP-tagged GR fragments is shown in Figure 2b. COS-1 cells
were lysed in cold IP buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1%
Triton-X) containing protease inhibitor cocktail (Roche Diagnosis, Mannheim,
Germany) and sonicated briefly to obtain whole lysates. Co-IP was carried out
using FLAG-agarose affinity gel (A2220, Sigma, St. Louis, Missouri) or anti-V5
antibody (46-0705, Invitrogen) combined with Dynabeads protein G (Invitrogen)
for 2 to 4 hours at 4°C. After the incubation, resin or beads were washed in
cold tris-buffered saline (TBS) (for FLAG-agarose resin) or IP buffer (for
Dynabeads) 4 times. Immunoprecipitated proteins were eluted in 2× SDS sample
buffer by heating at 70°C for 10 min. Eluted proteins were subjected to Western
blot analysis.
Figure 2.
CCRP facilitated the GR N/C interaction between the VMDFY residues and
the LBD.
Note. (a) Partial amino acid sequences of the NTD
regions of human GR and AR. The AR FQNLF and the GR VMDFY residues are
underlined, and hydrophobic residues within these residues are shown in
bold. Arginine residues which have additive effects on the AR N/C
interaction and corresponding arginine residues in the GR NTD are also
shown in bold. Flanking numbers above and below the sequences indicate
amino acid residue position. (b) Schematic representation of FLAG- and
EYFP-tagged GR fragments used in co-IP assays. Mutations with in VMDFY
motif are also indicated. (c) Interaction of FLAG-GRΔ26-76 with
EYFP-mock or EYFP-26/76 in the absence or presence of CCRP-V5. (d)
Interaction of FLAG-GRΔ26-76 or FLAG-GRΔ26-76ΔLBD with EYFP-26/76 in the
absence or presence of CCRP-V5. (e) Interaction of FLAG-GRΔ26-76 with
EYFP-26/76 (WT, VMDFY; AADFY; VMDAA) in the absence or presence of
CCRP-V5. (f) Interaction of FLAG-GRΔ26-76 with EYFP-26/76 (WT, VMDFY;
Y30F, VMDFF; Y30E, VMDFE) in the absence or presence of CCRP-V5. (c-f)
EYFP-26/76, FLAG-GRΔ26-76, and CCRP-V5 or pcDNA3.1-V5 were transiently
expressed. Whole lysates were prepared in IP buffer and co-
immunoprecipitation assays were performed using anti-FLAG agarose.
Co-immunoprecipitated proteins were eluted and subjected to Western blot
analysis. Anti-FLAG antibody and anti-GFP antibody were used to detect
FLAG-GRΔ26-76 and EYFP-26/76, respectively. CCRP = cytoplasmic
constitutive active/androstane receptor retention protein; GR =
glucocorticoid receptor; LBD = ligand binding domain; NTD, N-terminus
domain; AR = androgen receptor; EYFP = enhanced yellow fluorescent
protein; GFP = green fluorescent protein.
Western Blot Analysis
Proteins were separated with 8.5% SDS-PAGE and transferred to polyvinylidene
difluoride (PVDF) membrane. After blocking with 5% nonfat dry milk containing
TBS-0.1% Tween 20 buffer, membrane was probed with antibodies in the blocking
buffer for overnight at 4°C. For detection of FLAG-GR, CCRP-V5, and EYFP-26/76,
horseradish peroxidase (HRP) conjugating anti-FLAG antibody (1:5000, A8592,
Sigma), anti-V5 antibody (1:5000, 46-0708, Invitrogen), and anti-green
fluorescent protein (GFP) antibody (1:10000, ab6663, Abcam, Cambridge, UK) were
used, respectively. Protein bands on membrane were visualized using enhanced
chemiluminescence detection reagent (Advansta, Menlo Park, California).
Two-Dimensional Blue Native/Sodium Dodecyl Sulfate-Polyacrylamide Gel
Electrophoresis
Two-Dimensional Blue Native/Sodium Dodecyl Sulfate-Polyacrylamide Gel
Electrophoresis (2D-BN/SDS-PAGE) is a powerful tool to analyze multiprotein
complexes. Combined BN-PAGE with SDS-PAGE was shown to result in the separation
of several individual subunits of the resolved complexes, offering an
interesting 2-dimensional electrophoresis approach that allows us to profile
target molecule containing protein complexes. According to Wittig et al,[18] 2D-BN/SDS-PAGE was performed with modifications as follows. Cells were
lysed in low salt HEGMS buffer (20 mM HEPES pH 7.6, 50 mM NaCl, 15% Glycerol, 1
mM Na2MoO4, 1 mM EDTA) containing protease inhibitor
cocktail (Roche) and sonicated briefly. For a Triton-X containing experiment,
low salt HEGMS buffer containing 0.5% Triton-X was used for sample preparation.
After the centrifugation at 11 000 g for 5 minutes, clear supernatants were
collected as whole lysates. Then, one-tenth volume of 10× BN sample buffer (2.5%
CBB G-250, 100 mM Bis-Tris-HCl, pH 7.0, 500 mM 6-aminocaproic acid) was added to
each sample. Samples were incubated on ice for 5 to 10 minutes, and 20 µg
proteins were loaded to a 4% to 16% gradient native gel (Invitrogen). The first
dimensional electrophoresis was performed using appropriate cathode buffer (50
mM Tricine-HCl, 15 mM Bis-Tris-HCl, pH 7.0, 0.02% CBB G-250) and anode buffer
(50 mM Bis-Tris-HCl, pH 7.0) at 4°C to 7°C for 2 to 3 hours. Power supply was
set at 150 V. After the electrophoresis, each lane was excised from the first
dimensional BN gel and incubated in SDS-PAGE running buffer for 15 to 20
minutes. Each excised gel was placed onto an 8.5% SDS denaturing polyacrylamide
gel and covered with an SDS stacking gel. After the polymerization, the second
dimensional electrophoresis was performed at 180 V for 1 hour at room
temperature. Then, a Western blot analysis was carried out as described
above.
Nuclear and Cytoplasmic Protein Preparation
After 1 hour treatment with 0.1% dimethyl sulfoxide (DMSO) or 100 nM
dexamethasone, nuclear and cytoplasmic proteins were extracted from COS-1 cells
using NE-PER kit (PIERCE, Rockford, Illinois) according to the manufacturer’s
protocol. Then, a Western blot analysis was carried out as described above. To
confirm successful fractionation, protein levels of HSP90 and histone
deacetylase 1 (HDAC1) were determined with anti-HSP90 antibody (1:1000, 610419,
BD Transduction Laboratories, San Jose, California) and anti-HDAC1 antibody
(1:1000, 2062, Cell Signaling Technology, Danvers, Massachusetts),
respectively.
Results
CCRP Facilitated the N/C Interaction Within GR
To confirm a previous finding that CCRP binds to LBD of GR,[17] a co-IP analysis was conducted using COS-1 cells overexpressing GR
deletion mutants (Figure
1a). As expected, GR∆LBD did not interact with CCRP while full length
GR and GR LBD were co-immunoprecipitated with CCRP (Figure 1b). This result confirmed the
previous finding that LBD is sufficient for the interaction with CCRP.
Figure 1.
CCRP interacted with the GR LBD.
Note. (a) Schematic representation of FLAG-tagged GR
proteins (full length, ΔNTD, ΔLBD, and LBD) used in co-IP assays. (b)
Interaction between CCRP and GR. CCRP-V5 and intact or truncated FLAG-GR
were transiently expressed in COS-1 cells. Whole lysates were prepared
and co-immunoprecipitation was performed using anti-V5 antibody.
Co-immunoprecipitated proteins were eluted and subjected to Western blot
analysis. Anti-FLAG antibody and anti-V5 antibody were used to detect
FLAG-GR and CCRP-V5, respectively. CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; GR = glucocorticoid
receptor; LBD = ligand binding domain; NTD = N-terminus domain.
CCRP interacted with the GR LBD.Note. (a) Schematic representation of FLAG-tagged GR
proteins (full length, ΔNTD, ΔLBD, and LBD) used in co-IP assays. (b)
Interaction betweenCCRP and GR. CCRP-V5 and intact or truncated FLAG-GR
were transiently expressed in COS-1 cells. Whole lysates were prepared
and co-immunoprecipitation was performed using anti-V5 antibody.
Co-immunoprecipitated proteins were eluted and subjected to Western blot
analysis. Anti-FLAG antibody and anti-V5 antibody were used to detect
FLAG-GR and CCRP-V5, respectively. CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; GR = glucocorticoid
receptor; LBD = ligand binding domain; NTD = N-terminus domain.Figure 2a shows partial
amino acid sequences of GR and AR NTD regions. AR has
23FXXLF26 motif in the NTD which forms an α-helix and
interacts with LBD.[1-4] In addition to this core
motif, 2 arginine residues flanking the motif have additive effects on the AR
N/C interaction.[19] When focusing on the hydrophobicity of amino acids, a similarity in the
NTD was found between AR and GR. At the corresponding positions to those in the
AR NTD, the GR NTD has hydrophobic amino acid residues, V, F, and Y within the
26VMDFY30 sequence, and 2 arginine residues near the
peptide. The 26VMDFYKT32 peptide was predicted to form an
α-helical conformation by GOR IV, a secondary structure prediction tool.[20] Thus, in terms of N/C interactions, the GR VMDFY residues were expected
to be equivalent in function to the FXXLF motif from the AR NTD.CCRP facilitated the GR N/C interaction between the VMDFY residues and
the LBD.Note. (a) Partial amino acid sequences of the NTD
regions of human GR and AR. The AR FQNLF and the GR VMDFY residues are
underlined, and hydrophobic residues within these residues are shown in
bold. Arginine residues which have additive effects on the AR N/C
interaction and corresponding arginine residues in the GR NTD are also
shown in bold. Flanking numbers above and below the sequences indicate
amino acid residue position. (b) Schematic representation of FLAG- and
EYFP-tagged GR fragments used in co-IP assays. Mutations with in VMDFY
motif are also indicated. (c) Interaction of FLAG-GRΔ26-76 with
EYFP-mock or EYFP-26/76 in the absence or presence of CCRP-V5. (d)
Interaction of FLAG-GRΔ26-76 or FLAG-GRΔ26-76ΔLBD with EYFP-26/76 in the
absence or presence of CCRP-V5. (e) Interaction of FLAG-GRΔ26-76 with
EYFP-26/76 (WT, VMDFY; AADFY; VMDAA) in the absence or presence of
CCRP-V5. (f) Interaction of FLAG-GRΔ26-76 with EYFP-26/76 (WT, VMDFY;
Y30F, VMDFF; Y30E, VMDFE) in the absence or presence of CCRP-V5. (c-f)
EYFP-26/76, FLAG-GRΔ26-76, and CCRP-V5 or pcDNA3.1-V5 were transiently
expressed. Whole lysates were prepared in IP buffer and co-
immunoprecipitation assays were performed using anti-FLAG agarose.
Co-immunoprecipitated proteins were eluted and subjected to Western blot
analysis. Anti-FLAG antibody and anti-GFP antibody were used to detect
FLAG-GRΔ26-76 and EYFP-26/76, respectively. CCRP = cytoplasmic
constitutive active/androstane receptor retention protein; GR =
glucocorticoid receptor; LBD = ligand binding domain; NTD, N-terminus
domain; AR = androgen receptor; EYFP = enhanced yellow fluorescent
protein; GFP = green fluorescent protein.To examine the interaction between the VMDFY containing region and the LBD and a
role of CCRP for the interaction, a series of co-IP assays was performed.
FLAG-tagged GR with deletion of 26-76 residues (referred as FLAG-GR∆26-76) and
EYFP-tagged 26-76 residues (referred as EYFP-26/76) were ectopically expressed
in COS-1 cells in the presence or absence of CCRP-V5 (Figure 2b). Utilizing total lysates,
whether or not EYFP-26/76 was co-immunoprecipitated with FLAG-GR∆26-76 was
checked by co-IP assays with FLAG affinity resin. For the detection of
EYFP-26/76, anti-GFP antibody was used. As expected, EYFP-26/76 was
co-immunoprecipitated with FLAG-GR∆26-76 while EYFP alone did not interact with
FLAG-GR∆26-76 at all (Figure
2c, lane 1 vs 3). Moreover, the interaction between EYFP-26/76 and
FLAG-GR∆26-76 was increased by the co-expression of CCRP-V5 (Figure 2c, lane 3 vs 4).
This interaction was almost completely abolished by the deletion of LBD (Figure 2d, lane 1, 2 vs 3,
4). In addition, only LBD tagged with FLAG was able to bind to EYFP-26/76 in the
presence of CCRP-V5 (data not shown). But, the interaction was more stable in
the combination with FLAG-GR∆26-76 for unknown reason. That is why FLAG-GR∆26-76
instead of FLAG-LBD was used in this study.Next, the contribution of hydrophobic amino acid residues of the VMDFY sequence
to the interaction was investigated by mutation assays. Amino acid substitution
from VMDFY to VMDAA completely abolished the interaction (Figure 2e, lane 1, 2 vs 5,
6) while VMDFY to AADFY substitution had less effect (Figure 2e, lane 1, 2 vs 3,
4). When tyrosine (Y30) was substituted to a phosphor-mimicking glutamic acid
(VMDFE) to introduce a negative charge, the interaction was
greatly decreased (Figure
2f, lane 1, 2 vs 5, 6) although the interaction of FLAG-GR∆26-76 with
EYFP-26/76 was increased by amino acid substitution to non-phosphor-mimicking
phenylalanine (VMDFF) (Figure 2f, lane 1, 2 vs 3, 4). These
results demonstrated that GR forms an N/C interaction between the VMDFY motif
and the LBD in a Y30-dependent manner and that CCRP facilitates the GR N/C
interaction.Furthermore, as shown in Figure
3, the interaction betweenCCRP-V5 and EYFP-26/76 was also greatly
increased by co-expression of FLAG-GR∆26-76 although EYFP-26/76 bearing Y30E
mutation did not interact with CCRP-V5 even in the presence of FLAG-GR∆26-76.
Taken together with results shown in Figure 2, it was indicated that CCRP
interacts with the GR LBD and recruits the VMDFY motif in the NTD to form the
N/C interaction.
Figure 3.
CCRP promoted the N/C interaction.
Note. Interaction of CCRP-V5 with EYFP-26/76 (WT, VMDFY;
Y30F, VMDFF; Y30E, VMDFE) in the absence or presence of FLAG-GRΔ26-76.
CCRP-V5, EYFP-26/76, and FLAG-GRΔ26-76 or pcDNA3.1-V5 were transiently
expressed. Whole lysates were prepared and co-immunoprecipitation was
performed using anti-V5 antibody. Co-immunoprecipitated proteins were
eluted and subjected to Western blot analysis. Anti-V5 antibody and
anti-GFP antibody were used to detect CCRP-V5 and EYFP-26/76,
respectively. CCRP = cytoplasmic constitutive active/androstane receptor
retention protein; EYFP = enhanced yellow fluorescent protein; GR =
glucocorticoid receptor; GFP = green fluorescent protein.
CCRP promoted the N/C interaction.Note. Interaction of CCRP-V5 with EYFP-26/76 (WT, VMDFY;
Y30F, VMDFF; Y30E, VMDFE) in the absence or presence of FLAG-GRΔ26-76.
CCRP-V5, EYFP-26/76, and FLAG-GRΔ26-76 or pcDNA3.1-V5 were transiently
expressed. Whole lysates were prepared and co-immunoprecipitation was
performed using anti-V5 antibody. Co-immunoprecipitated proteins were
eluted and subjected to Western blot analysis. Anti-V5 antibody and
anti-GFP antibody were used to detect CCRP-V5 and EYFP-26/76,
respectively. CCRP = cytoplasmic constitutive active/androstane receptor
retention protein; EYFP = enhanced yellow fluorescent protein; GR =
glucocorticoid receptor; GFP = green fluorescent protein.The effect of dexamethasone, a potent GR ligand, on the N/C interaction was also
investigated. Treatment of COS-1 cells with 1 and 100 nM dexamethasone had no
effect on the interaction between EYFP-26/76 and FLAG-GR∆26-76 regardless of
CCRP-V5 expression (Figure
4). This result suggested that the GR N/C interaction is
ligand-independent at least under our experimental conditions.
Figure 4.
DEX had no effect on the N/C interaction.
Note. FLAG-GRΔ26-76, EYFP-26/76, and CCRP-V5 or
pcDNA3.1-V5 were transiently expressed and cells were treated with 0, 1,
or 100 nM DEX for 1 hour at 37°C in 5% CO2 incubator. Whole
lysates were prepared in IP buffer and co-immunoprecipitation was
performed using anti-FLAG agarose. Co-immunoprecipitated proteins were
eluted and subjected to Western blot analysis. Anti-FLAG antibody and
anti-GFP antibody were used to detect FLAG-GRΔ26-76 and EYFP-26/76,
respectively. GR = glucocorticoid receptor; EYFP = enhanced yellow
fluorescent protein; CCRP = cytoplasmic constitutive active/androstane
receptor retention protein; DEX = dexamethasone; GFP = green fluorescent
protein.
DEX had no effect on the N/C interaction.Note. FLAG-GRΔ26-76, EYFP-26/76, and CCRP-V5 or
pcDNA3.1-V5 were transiently expressed and cells were treated with 0, 1,
or 100 nM DEX for 1 hour at 37°C in 5% CO2 incubator. Whole
lysates were prepared in IP buffer and co-immunoprecipitation was
performed using anti-FLAG agarose. Co-immunoprecipitated proteins were
eluted and subjected to Western blot analysis. Anti-FLAG antibody and
anti-GFP antibody were used to detect FLAG-GRΔ26-76 and EYFP-26/76,
respectively. GR = glucocorticoid receptor; EYFP = enhanced yellow
fluorescent protein; CCRP = cytoplasmic constitutive active/androstane
receptor retention protein; DEX = dexamethasone; GFP = green fluorescent
protein.
The CCRP-Mediated N/C Interaction Critically Regulated Protein-Protein
Interactions of GR
The effect of the CCRP-mediated N/C interaction was further investigated with
2D-BN-SDS-PAGE technique, which allows us to know total molecular weight of
multiple protein complexes. GR Y30F and Y30E mutants were utilized as N/C
interacting and noninteracting models. First, interactions of CCRP with Y30F and
Y30E mutants were confirmed by co-IP assay (Figure 5a). Both Y30F and Y30E bearing GR
were detected from 242 to over 1000 kDa in the absence of CCRP (Figure 5b, left panels).
Surprisingly, most of GR Y30F co-expressed with CCRP was detected at 242 kDa
while CCRP did not change the distribution pattern of GR Y30E (Figure 5b, right panels).
Thus, co-expression of CCRP decreased high molecular weight protein complexes
only when the GR N/C interaction could occur. Moreover, the addition of Triton-X
dissociated protein interactions at high molecular weight, and only 242-kDa
complex was remained in all samples (Figure 5c). These data indicated that the
242-kDa complex is formed independently of CCRP or the N/C interaction,
suggesting that CCRP-mediated N/C interaction inhibits protein interactions with
the 242-kDa GR complex.
Figure 5.
The CCRP-mediated N/C interaction determined GR protein complexes.
Note. (a) Interaction between CCRP-V5 and FLAG-GR
bearing Y30F or Y30E mutation. CCRP-V5 and FLAG-GR (Y30F or Y30E) were
transiently expressed. Whole lysates were prepared and
co-immunoprecipitation was performed using anti-V5 antibody.
Co-immunoprecipitated proteins were eluted and subjected to Western blot
analysis. Anti-V5 antibody and anti-FLAG antibodies were used to detect
CCRP-V5 and FLAG-GR, respectively. (b, c) 2D-BN/SDS-PAGE analyses showed
that the CCRP-mediated N/C interaction dissociated proteins from GR
protein complex detected at around 242 kDa. FLAG-GR (Y30F or Y30E) and
CCRP-V5 or pcDNA3.1-V5 were transiently expressed and total lysates were
prepared in low salt HEGMS buffer (b) or 0.1% Triton-X containing low
salt HEGMS buffer (c). Samples were loaded on a 4% to 16% BN gel (the
first dimension) followed by the second dimension separation using 8.5%
SDS-PAGE gels and Western blotting. Anti-FLAG antibody detected FLAG-GR
at around 100 kDa as expected. CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; GR = glucocorticoid
receptor; 2D-BN/SDS-PAGE = 2-dimensional blue native/sodium dodecyl
sulfate-polyacrylamide gel electrophoresis.
The CCRP-mediated N/C interaction determined GR protein complexes.Note. (a) Interaction betweenCCRP-V5 and FLAG-GR
bearing Y30F or Y30E mutation. CCRP-V5 and FLAG-GR (Y30F or Y30E) were
transiently expressed. Whole lysates were prepared and
co-immunoprecipitation was performed using anti-V5 antibody.
Co-immunoprecipitated proteins were eluted and subjected to Western blot
analysis. Anti-V5 antibody and anti-FLAG antibodies were used to detect
CCRP-V5 and FLAG-GR, respectively. (b, c) 2D-BN/SDS-PAGE analyses showed
that the CCRP-mediated N/C interaction dissociated proteins from GR
protein complex detected at around 242 kDa. FLAG-GR (Y30F or Y30E) and
CCRP-V5 or pcDNA3.1-V5 were transiently expressed and total lysates were
prepared in low salt HEGMS buffer (b) or 0.1% Triton-X containing low
salt HEGMS buffer (c). Samples were loaded on a 4% to 16% BN gel (the
first dimension) followed by the second dimension separation using 8.5%
SDS-PAGE gels and Western blotting. Anti-FLAG antibody detected FLAG-GR
at around 100 kDa as expected. CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; GR = glucocorticoid
receptor; 2D-BN/SDS-PAGE = 2-dimensional blue native/sodium dodecyl
sulfate-polyacrylamide gel electrophoresis.
The N/C Interaction Did Not Regulate Intracellular Localization of GR
CCRP-V5 and GR Y30F or Y30E were overexpressed in COS-1 cells, and cells were
treated with vehicle DMSO or 100 nM dexamethasone for 1 hour. Their
intracellular localizations were determined by Western blots (Figure 6). CCRP was mainly
localized in the cytoplasm before and after DEX treatment. GR Y30E, which was
unable to form the N/C interaction, accumulated in the nucleus after DEX
treatment as observed with the Y30F. Thus, it was suggested that the N/C
interaction plays no role in the regulation of GR nuclear in response to
DEX.
Figure 6.
GR does not require the GR N/C interaction for nuclear translocation.
Note. Western blot analysis showed intracellular
localization of GR bearing Y30F or Y30E mutation after treatment with
vehicle or dexamethasone. CCRP-V5 and FLAG-GR (Y30F or Y30E) were
transiently expressed and cells were treated with vehicle (0.1% DMSO) or
100 nM dexamethasone for 1 hour at 37°C in a 5% CO2
incubator. Cytoplasmic and nuclear proteins were extracted, followed by
Western blot analysis. Anti-FLAG and V5 antibodies were used to detect
FLAG-GR and CCRP-V5, respectively. Fractionation was confirmed by
abundance of control proteins (HSP90 for cytoplasm and HDAC1 for
nuclei). GR = glucocorticoid receptor; CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; DMSO = dimethyl
sulfoxide.
GR does not require the GR N/C interaction for nuclear translocation.Note. Western blot analysis showed intracellular
localization of GR bearing Y30F or Y30E mutation after treatment with
vehicle or dexamethasone. CCRP-V5 and FLAG-GR (Y30F or Y30E) were
transiently expressed and cells were treated with vehicle (0.1% DMSO) or
100 nM dexamethasone for 1 hour at 37°C in a 5% CO2
incubator. Cytoplasmic and nuclear proteins were extracted, followed by
Western blot analysis. Anti-FLAG and V5 antibodies were used to detect
FLAG-GR and CCRP-V5, respectively. Fractionation was confirmed by
abundance of control proteins (HSP90 for cytoplasm and HDAC1 for
nuclei). GR = glucocorticoid receptor; CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; DMSO = dimethyl
sulfoxide.
Discussion
Here, we have demonstrated that CCRP facilitates GR to form the N/C interaction.
Although deletion of the LBD enabled GR to elicit the NTD-dependent transcriptional
activity, attempts to demonstrate any types of intramolecular interaction to support
this NTD function have not been successful. For example, the LBD was unable to
repress the NTD-dependent transactivation of a reporter gene when C- and N-terminal
GR fragments were co-expressed in cell-based transfection assays.[21] Mammalian 2-hybrid assays also failed to show the LBD/NTD interaction.[11] Noticeably, these previous experiments were performed in CV-1 or CV-1-derived
COS-1 cells. These cells are not suitable to investigate the N/C interaction as they
do not express endogenous CCRP and because CCRP is essential for GR to form the
interaction. In supporting the role of CCRP in the interaction, yeastHsp40Ydj1,
which interacts with GR via its J-domain enabled the GR LBD to repress its
NTD-mediated transcription activity in yeast-based reporter assays.[22]The 23FQNLF26 peptide of AR, which regulates the N/C
interaction, is generally represented as the FXXLF motif. It is because the
hydrophobic residues at both ends determine functionality as indicated by the fact
that either AQNLF or FQNAA mutants abolished the
AR N/C interaction.[2] In GR, whereas 26AADFY30 mutant
modestly decreased N/C interaction, 26VMDAA30
mutant abolished it. Thus, the functionality of the 26VMDFY30
peptide somewhat resembles that of the FXXLF motif in AR. However, what is unique to
GR was that the motif peptide ends by tyrosine, of which single mutation to a
similar size negatively charged glutamic acid (Y30E), but not to phenylalanine
(Y30F), was sufficient to abolish the N/C interaction of GR. Thus, Y30 appears to be
the most critical residue for GR to regulate the N/C interaction. As glutamic acid
often exhibits a characteristic of phosphorylated tyrosine, the VMDFY motif could be
phosphorylated to regulate the N/C interaction. As the phosphorylation of AR at S16
near to the FXXLF motif was shown to decrease the AR N/C interaction, the
phosphorylation-dependent regulation of the N/C interaction of nuclear receptors has
been suggested.[5] Cell signals eliciting phosphorylation and the protein kinase that
phosphorylates Y30 must be identified to further understanding of the GR N/C
interaction in future investigations. In addition, the VMDFY motif in GR is highly
conserved among species, especially mammals (Figure 7). It suggests an importance of the
VMDFY motif in the regulation of GR functions.
Figure 7.
GR conserves the VMDFY motif cross species.
Note. The VMDFY motifs and flanking arginine residues are
shown in bold and residues of which polarity is similar to the VMDFY motif
at each corresponding position are underlined. GR = glucocorticoid
receptor.
GR conserves the VMDFY motif cross species.Note. The VMDFY motifs and flanking arginine residues are
shown in bold and residues of which polarity is similar to the VMDFY motif
at each corresponding position are underlined. GR = glucocorticoid
receptor.Our 2D-BN/SDS-PAGE analysis showed that CCRP regulates GR protein complexes in an
Y30-dependent manner. Both Y30E and Y30F formed a streak of larger complexes
beginning with a size of approximately 242 kDa. Hedman et al reported the presence
of multiple GR complexes with sizes ranging from 250 to 400 kDa in rat liver
cytosolic fractions.[23] Thus, GR complexes formed in COS-1 cells are similar to those observed in rat
livers. CCRP dissociated all Y30F, but not Y30E, complexes greater than 242 kDa in
size. Based on its size, this 242-kDa protein may be a complex with 2 GR monomers.
In fact, GR was previously shown to form a homodimer ligand independently.[24] From the result that the 242-kDa complex was formed regardless of CCRP or
mutations at Y30, the N/C interaction may not affect the GR homodimerization. The
present study also showed that the intracellular localization of GR in the absence
or presence of dexamethasone was not affected by the N/C interaction. Instead,
because regions of the NTD and the LBD provide interaction surfaces to
transcription-related proteins, the GR N/C interaction would modify interactions
with these proteins as reported for AR.[1-4] The N/C interaction may enable
GR to regulate unique genes as suggested by cDNA microarrays (Supplemental Figure 2).Collectively, we have now demonstrated that a GR peptide near the N-terminus
(26VMDFY30) interacts with the LBD and forms the N/C
interaction. Moreover, co-chaperoneCCRP was found to bind the LBD to facilitate the
GR N/C interaction. We show an expected model of the CCRP-mediated GR N/C
interaction in Figure 8.
While N/C interactions were previously observed in various nuclear receptors (eg,
AR, PR, ER, and MR), GR is the first nuclear receptor for which the N/C interaction
is regulated by a co-chaperone. Our current findings will provide new insights into
how co-chaperone proteins regulate nuclear receptors and how nuclear receptors
regulate different genes and different pathways.
Figure 8.
Schematic representation of the CCRP-mediated GR N/C interaction.
Note. Based on experimental results, the role of CCRP in the
N/C interaction is modeled. GR is unable to form the N/C interaction when
Y30 is phosphorylated. Upon dephosphorylation, GR enables for CCRP to
stimulate the interaction. CCRP appears to dissociate from GR after it
formed the interaction since interaction of CCRP with GR deleted with NTD
and Y30E, which do not form the N/C interaction, was more stable than that
with full length and wild type GR. CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; GR = glucocorticoid receptor;
NTD = N-terminus domain.
Schematic representation of the CCRP-mediated GR N/C interaction.Note. Based on experimental results, the role of CCRP in the
N/C interaction is modeled. GR is unable to form the N/C interaction when
Y30 is phosphorylated. Upon dephosphorylation, GR enables for CCRP to
stimulate the interaction. CCRP appears to dissociate from GR after it
formed the interaction since interaction of CCRP with GR deleted with NTD
and Y30E, which do not form the N/C interaction, was more stable than that
with full length and wild type GR. CCRP = cytoplasmic constitutive
active/androstane receptor retention protein; GR = glucocorticoid receptor;
NTD = N-terminus domain.Click here for additional data file.Supplemental material, Ohno_Supplemental_Fig_1 for GR Utilizes a Co-Chaperone
Cytoplasmic CAR Retention Protein to Form an N/C Interaction by Marumi Ohno and
Masahiko Negishi in Nuclear Receptor SignalingClick here for additional data file.Supplemental material, Ohno_Supplemental_Fig_2 for GR Utilizes a Co-Chaperone
Cytoplasmic CAR Retention Protein to Form an N/C Interaction by Marumi Ohno and
Masahiko Negishi in Nuclear Receptor SignalingClick here for additional data file.Supplemental material, Supplemental_Figure_Captions for GR Utilizes a
Co-Chaperone Cytoplasmic CAR Retention Protein to Form an N/C Interaction by
Marumi Ohno and Masahiko Negishi in Nuclear Receptor Signaling
Authors: Bin He; Robert T Gampe; Adam J Kole; Andrew T Hnat; Thomas B Stanley; Gang An; Eugene L Stewart; Rebecca I Kalman; John T Minges; Elizabeth M Wilson Journal: Mol Cell Date: 2004-11-05 Impact factor: 17.970
Authors: Alexander Brychzy; Theo Rein; Konstanze F Winklhofer; F Ulrich Hartl; Jason C Young; Wolfgang M J Obermann Journal: EMBO J Date: 2003-07-15 Impact factor: 11.598